nodes	percent_of_prediction	percent_of_DWPC	metapath
Methacholine—Cholinergic syndrome—Irinotecan—breast cancer	0.0823	0.0978	CcSEcCtD
Methacholine—L-Carnitine—CPT1A—breast cancer	0.0275	0.651	CrCbGaD
Methacholine—Throat irritation—Tamoxifen—breast cancer	0.0193	0.0229	CcSEcCtD
Methacholine—Atrioventricular block complete—Paclitaxel—breast cancer	0.016	0.019	CcSEcCtD
Methacholine—Respiratory distress—Melphalan—breast cancer	0.015	0.0178	CcSEcCtD
Methacholine—L-Carnitine—SLCO1B1—breast cancer	0.0148	0.349	CrCbGaD
Methacholine—Lightheadedness—Letrozole—breast cancer	0.0127	0.0151	CcSEcCtD
Methacholine—Chest tightness—Docetaxel—breast cancer	0.0101	0.012	CcSEcCtD
Methacholine—Chest tightness—Capecitabine—breast cancer	0.00979	0.0116	CcSEcCtD
Methacholine—Respiratory distress—Paclitaxel—breast cancer	0.00881	0.0105	CcSEcCtD
Methacholine—Lightheadedness—Tamoxifen—breast cancer	0.0087	0.0103	CcSEcCtD
Methacholine—Retrosternal pain—Epirubicin—breast cancer	0.00794	0.00943	CcSEcCtD
Methacholine—Cough—Lapatinib—breast cancer	0.00764	0.00907	CcSEcCtD
Methacholine—Retrosternal pain—Doxorubicin—breast cancer	0.00735	0.00873	CcSEcCtD
Methacholine—Respiratory distress—Capecitabine—breast cancer	0.00723	0.00858	CcSEcCtD
Methacholine—Cough—Fulvestrant—breast cancer	0.00702	0.00834	CcSEcCtD
Methacholine—Chest pain—Fulvestrant—breast cancer	0.00685	0.00814	CcSEcCtD
Methacholine—Chest pain—Toremifene—breast cancer	0.00676	0.00803	CcSEcCtD
Methacholine—Cardiac arrest—Melphalan—breast cancer	0.00657	0.00781	CcSEcCtD
Methacholine—Chest discomfort—Paclitaxel—breast cancer	0.00632	0.00751	CcSEcCtD
Methacholine—Headache—Fluoxymesterone—breast cancer	0.0063	0.00749	CcSEcCtD
Methacholine—Cough—Exemestane—breast cancer	0.0061	0.00725	CcSEcCtD
Methacholine—Nausea—Fluoxymesterone—breast cancer	0.00598	0.0071	CcSEcCtD
Methacholine—Chest pain—Exemestane—breast cancer	0.00595	0.00707	CcSEcCtD
Methacholine—Syncope—Ixabepilone—breast cancer	0.00592	0.00703	CcSEcCtD
Methacholine—Bronchospasm—Melphalan—breast cancer	0.00588	0.00698	CcSEcCtD
Methacholine—Loss of consciousness—Ixabepilone—breast cancer	0.0058	0.00689	CcSEcCtD
Methacholine—Cough—Ixabepilone—breast cancer	0.00576	0.00684	CcSEcCtD
Methacholine—Chest pain—Ixabepilone—breast cancer	0.00562	0.00667	CcSEcCtD
Methacholine—Cardiac arrest—Thiotepa—breast cancer	0.00548	0.00651	CcSEcCtD
Methacholine—Wheezing—Paclitaxel—breast cancer	0.00543	0.00645	CcSEcCtD
Methacholine—Cough—Letrozole—breast cancer	0.00542	0.00644	CcSEcCtD
Methacholine—Cough—Anastrozole—breast cancer	0.00542	0.00644	CcSEcCtD
Methacholine—Chest discomfort—Docetaxel—breast cancer	0.00536	0.00637	CcSEcCtD
Methacholine—Shock—Ixabepilone—breast cancer	0.0053	0.00629	CcSEcCtD
Methacholine—Chest pain—Anastrozole—breast cancer	0.00529	0.00628	CcSEcCtD
Methacholine—Chest pain—Letrozole—breast cancer	0.00529	0.00628	CcSEcCtD
Methacholine—Syncope—Raloxifene—breast cancer	0.00529	0.00628	CcSEcCtD
Methacholine—Chest discomfort—Capecitabine—breast cancer	0.00519	0.00616	CcSEcCtD
Methacholine—Loss of consciousness—Raloxifene—breast cancer	0.00518	0.00615	CcSEcCtD
Methacholine—Cough—Raloxifene—breast cancer	0.00514	0.00611	CcSEcCtD
Methacholine—Bronchospasm—Vinorelbine—breast cancer	0.00513	0.0061	CcSEcCtD
Methacholine—Pruritus—Lapatinib—breast cancer	0.00505	0.006	CcSEcCtD
Methacholine—Hypotension—Ixabepilone—breast cancer	0.00503	0.00597	CcSEcCtD
Methacholine—Chest pain—Raloxifene—breast cancer	0.00502	0.00596	CcSEcCtD
Methacholine—Chest pain—Idarubicin—breast cancer	0.00502	0.00596	CcSEcCtD
Methacholine—Lightheadedness—Paclitaxel—breast cancer	0.00501	0.00595	CcSEcCtD
Methacholine—Cardiac arrest—Irinotecan—breast cancer	0.00473	0.00562	CcSEcCtD
Methacholine—Shock—Idarubicin—breast cancer	0.00473	0.00562	CcSEcCtD
Methacholine—Shock—Raloxifene—breast cancer	0.00473	0.00562	CcSEcCtD
Methacholine—Pruritus—Fulvestrant—breast cancer	0.00465	0.00552	CcSEcCtD
Methacholine—Pruritus—Toremifene—breast cancer	0.00459	0.00545	CcSEcCtD
Methacholine—Vomiting—Lapatinib—breast cancer	0.00454	0.00539	CcSEcCtD
Methacholine—Cardiac arrest—Fluorouracil—breast cancer	0.00453	0.00539	CcSEcCtD
Methacholine—Headache—Lapatinib—breast cancer	0.00447	0.00531	CcSEcCtD
Methacholine—Dizziness—Fulvestrant—breast cancer	0.00434	0.00516	CcSEcCtD
Methacholine—Dizziness—Toremifene—breast cancer	0.00429	0.00509	CcSEcCtD
Methacholine—Lightheadedness—Docetaxel—breast cancer	0.00424	0.00504	CcSEcCtD
Methacholine—Nausea—Lapatinib—breast cancer	0.00424	0.00504	CcSEcCtD
Methacholine—Vomiting—Fulvestrant—breast cancer	0.00418	0.00496	CcSEcCtD
Methacholine—Bronchospasm—Gemcitabine—breast cancer	0.00412	0.0049	CcSEcCtD
Methacholine—Vomiting—Toremifene—breast cancer	0.00412	0.0049	CcSEcCtD
Methacholine—Headache—Fulvestrant—breast cancer	0.00411	0.00489	CcSEcCtD
Methacholine—Headache—Toremifene—breast cancer	0.00406	0.00482	CcSEcCtD
Methacholine—Pruritus—Exemestane—breast cancer	0.00404	0.00479	CcSEcCtD
Methacholine—Nausea—Fulvestrant—breast cancer	0.0039	0.00463	CcSEcCtD
Methacholine—Cardiac arrest—Paclitaxel—breast cancer	0.00386	0.00459	CcSEcCtD
Methacholine—Nausea—Toremifene—breast cancer	0.00385	0.00457	CcSEcCtD
Methacholine—Pruritus—Ixabepilone—breast cancer	0.00381	0.00452	CcSEcCtD
Methacholine—Dizziness—Exemestane—breast cancer	0.00377	0.00448	CcSEcCtD
Methacholine—Cough—Tamoxifen—breast cancer	0.00371	0.00441	CcSEcCtD
Methacholine—Cough—Melphalan—breast cancer	0.00363	0.00431	CcSEcCtD
Methacholine—Vomiting—Exemestane—breast cancer	0.00363	0.00431	CcSEcCtD
Methacholine—Chest pain—Tamoxifen—breast cancer	0.00362	0.0043	CcSEcCtD
Methacholine—Pruritus—Anastrozole—breast cancer	0.00359	0.00426	CcSEcCtD
Methacholine—Pruritus—Letrozole—breast cancer	0.00359	0.00426	CcSEcCtD
Methacholine—Headache—Exemestane—breast cancer	0.00357	0.00425	CcSEcCtD
Methacholine—Dizziness—Ixabepilone—breast cancer	0.00356	0.00423	CcSEcCtD
Methacholine—Chest pain—Melphalan—breast cancer	0.00354	0.00421	CcSEcCtD
Methacholine—Cough—Goserelin—breast cancer	0.00354	0.00421	CcSEcCtD
Methacholine—Bradycardia—Irinotecan—breast cancer	0.00351	0.00417	CcSEcCtD
Methacholine—Bradycardia—Mitoxantrone—breast cancer	0.00351	0.00417	CcSEcCtD
Methacholine—Chest pain—Goserelin—breast cancer	0.00346	0.00411	CcSEcCtD
Methacholine—Vomiting—Ixabepilone—breast cancer	0.00342	0.00407	CcSEcCtD
Methacholine—Nausea—Exemestane—breast cancer	0.00339	0.00403	CcSEcCtD
Methacholine—Headache—Ixabepilone—breast cancer	0.00337	0.00401	CcSEcCtD
Methacholine—Dizziness—Anastrozole—breast cancer	0.00335	0.00398	CcSEcCtD
Methacholine—Dizziness—Letrozole—breast cancer	0.00335	0.00398	CcSEcCtD
Methacholine—Shock—Goserelin—breast cancer	0.00326	0.00387	CcSEcCtD
Methacholine—Vomiting—Anastrozole—breast cancer	0.00322	0.00383	CcSEcCtD
Methacholine—Vomiting—Letrozole—breast cancer	0.00322	0.00383	CcSEcCtD
Methacholine—Nausea—Ixabepilone—breast cancer	0.0032	0.0038	CcSEcCtD
Methacholine—Dizziness—Raloxifene—breast cancer	0.00318	0.00378	CcSEcCtD
Methacholine—Headache—Anastrozole—breast cancer	0.00318	0.00377	CcSEcCtD
Methacholine—Headache—Letrozole—breast cancer	0.00318	0.00377	CcSEcCtD
Methacholine—Hypotension—Melphalan—breast cancer	0.00317	0.00377	CcSEcCtD
Methacholine—Cough—Vinorelbine—breast cancer	0.00317	0.00377	CcSEcCtD
Methacholine—Cardiac arrest—Capecitabine—breast cancer	0.00317	0.00376	CcSEcCtD
Methacholine—Hypotension—Goserelin—breast cancer	0.0031	0.00368	CcSEcCtD
Methacholine—Chest pain—Vinorelbine—breast cancer	0.0031	0.00368	CcSEcCtD
Methacholine—Vomiting—Idarubicin—breast cancer	0.00306	0.00363	CcSEcCtD
Methacholine—Vomiting—Raloxifene—breast cancer	0.00306	0.00363	CcSEcCtD
Methacholine—Cough—Thiotepa—breast cancer	0.00303	0.0036	CcSEcCtD
Methacholine—Headache—Idarubicin—breast cancer	0.00301	0.00358	CcSEcCtD
Methacholine—Headache—Raloxifene—breast cancer	0.00301	0.00358	CcSEcCtD
Methacholine—Nausea—Letrozole—breast cancer	0.00301	0.00358	CcSEcCtD
Methacholine—Nausea—Anastrozole—breast cancer	0.00301	0.00358	CcSEcCtD
Methacholine—Bronchospasm—Docetaxel—breast cancer	0.00293	0.00348	CcSEcCtD
Methacholine—Bradycardia—Paclitaxel—breast cancer	0.00286	0.0034	CcSEcCtD
Methacholine—Nausea—Idarubicin—breast cancer	0.00286	0.00339	CcSEcCtD
Methacholine—Nausea—Raloxifene—breast cancer	0.00286	0.00339	CcSEcCtD
Methacholine—Bronchospasm—Capecitabine—breast cancer	0.00283	0.00337	CcSEcCtD
Methacholine—Hypotension—Vinorelbine—breast cancer	0.00277	0.00329	CcSEcCtD
Methacholine—Pruritus—Chlorambucil—breast cancer	0.00276	0.00327	CcSEcCtD
Methacholine—Syncope—Irinotecan—breast cancer	0.00269	0.00319	CcSEcCtD
Methacholine—Loss of consciousness—Irinotecan—breast cancer	0.00264	0.00313	CcSEcCtD
Methacholine—Cough—Mitoxantrone—breast cancer	0.00262	0.00311	CcSEcCtD
Methacholine—Cough—Irinotecan—breast cancer	0.00262	0.00311	CcSEcCtD
Methacholine—Chest pain—Mitoxantrone—breast cancer	0.00255	0.00303	CcSEcCtD
Methacholine—Cough—Gemcitabine—breast cancer	0.00255	0.00303	CcSEcCtD
Methacholine—Chest pain—Gemcitabine—breast cancer	0.00249	0.00295	CcSEcCtD
Methacholine—Vomiting—Chlorambucil—breast cancer	0.00248	0.00294	CcSEcCtD
Methacholine—Pruritus—Tamoxifen—breast cancer	0.00245	0.00292	CcSEcCtD
Methacholine—Chest pain—Fluorouracil—breast cancer	0.00245	0.0029	CcSEcCtD
Methacholine—Shock—Mitoxantrone—breast cancer	0.00241	0.00286	CcSEcCtD
Methacholine—Shock—Irinotecan—breast cancer	0.00241	0.00286	CcSEcCtD
Methacholine—Pruritus—Melphalan—breast cancer	0.0024	0.00285	CcSEcCtD
Methacholine—Dizziness—Vinblastine—breast cancer	0.00236	0.0028	CcSEcCtD
Methacholine—Bradycardia—Capecitabine—breast cancer	0.00235	0.00279	CcSEcCtD
Methacholine—Pruritus—Goserelin—breast cancer	0.00234	0.00278	CcSEcCtD
Methacholine—Nausea—Chlorambucil—breast cancer	0.00231	0.00275	CcSEcCtD
Methacholine—Dizziness—Tamoxifen—breast cancer	0.00229	0.00272	CcSEcCtD
Methacholine—Hypotension—Mitoxantrone—breast cancer	0.00229	0.00272	CcSEcCtD
Methacholine—Hypotension—Irinotecan—breast cancer	0.00229	0.00272	CcSEcCtD
Methacholine—Vomiting—Vinblastine—breast cancer	0.00227	0.0027	CcSEcCtD
Methacholine—Headache—Vinblastine—breast cancer	0.00224	0.00266	CcSEcCtD
Methacholine—Hypotension—Gemcitabine—breast cancer	0.00223	0.00265	CcSEcCtD
Methacholine—Cardiac arrest—Epirubicin—breast cancer	0.00221	0.00262	CcSEcCtD
Methacholine—Vomiting—Tamoxifen—breast cancer	0.00221	0.00262	CcSEcCtD
Methacholine—Syncope—Paclitaxel—breast cancer	0.00219	0.00261	CcSEcCtD
Methacholine—Dizziness—Goserelin—breast cancer	0.00219	0.0026	CcSEcCtD
Methacholine—Hypotension—Fluorouracil—breast cancer	0.00219	0.0026	CcSEcCtD
Methacholine—Headache—Tamoxifen—breast cancer	0.00217	0.00258	CcSEcCtD
Methacholine—Vomiting—Melphalan—breast cancer	0.00216	0.00257	CcSEcCtD
Methacholine—Loss of consciousness—Paclitaxel—breast cancer	0.00215	0.00255	CcSEcCtD
Methacholine—Cough—Paclitaxel—breast cancer	0.00213	0.00253	CcSEcCtD
Methacholine—Nausea—Vinblastine—breast cancer	0.00212	0.00252	CcSEcCtD
Methacholine—Vomiting—Goserelin—breast cancer	0.00211	0.0025	CcSEcCtD
Methacholine—Pruritus—Vinorelbine—breast cancer	0.0021	0.00249	CcSEcCtD
Methacholine—Chest pain—Paclitaxel—breast cancer	0.00208	0.00247	CcSEcCtD
Methacholine—Headache—Goserelin—breast cancer	0.00208	0.00247	CcSEcCtD
Methacholine—Nausea—Tamoxifen—breast cancer	0.00206	0.00245	CcSEcCtD
Methacholine—Cardiac arrest—Doxorubicin—breast cancer	0.00204	0.00243	CcSEcCtD
Methacholine—Nausea—Melphalan—breast cancer	0.00202	0.0024	CcSEcCtD
Methacholine—Pruritus—Thiotepa—breast cancer	0.00201	0.00238	CcSEcCtD
Methacholine—Nausea—Goserelin—breast cancer	0.00197	0.00234	CcSEcCtD
Methacholine—Shock—Paclitaxel—breast cancer	0.00196	0.00233	CcSEcCtD
Methacholine—Dizziness—Vinorelbine—breast cancer	0.00196	0.00233	CcSEcCtD
Methacholine—Vomiting—Vinorelbine—breast cancer	0.00189	0.00224	CcSEcCtD
Methacholine—Dizziness—Thiotepa—breast cancer	0.00187	0.00223	CcSEcCtD
Methacholine—Hypotension—Paclitaxel—breast cancer	0.00187	0.00222	CcSEcCtD
Methacholine—Headache—Vinorelbine—breast cancer	0.00186	0.00221	CcSEcCtD
Methacholine—Syncope—Docetaxel—breast cancer	0.00186	0.00221	CcSEcCtD
Methacholine—Loss of consciousness—Docetaxel—breast cancer	0.00182	0.00216	CcSEcCtD
Methacholine—Cough—Docetaxel—breast cancer	0.00181	0.00215	CcSEcCtD
Methacholine—Vomiting—Thiotepa—breast cancer	0.0018	0.00214	CcSEcCtD
Methacholine—Syncope—Capecitabine—breast cancer	0.0018	0.00214	CcSEcCtD
Methacholine—Headache—Thiotepa—breast cancer	0.00178	0.00211	CcSEcCtD
Methacholine—Chest pain—Docetaxel—breast cancer	0.00176	0.0021	CcSEcCtD
Methacholine—Loss of consciousness—Capecitabine—breast cancer	0.00176	0.0021	CcSEcCtD
Methacholine—Nausea—Vinorelbine—breast cancer	0.00176	0.00209	CcSEcCtD
Methacholine—Cough—Capecitabine—breast cancer	0.00175	0.00208	CcSEcCtD
Methacholine—Chest pain—Capecitabine—breast cancer	0.00171	0.00203	CcSEcCtD
Methacholine—Pruritus—Gemcitabine—breast cancer	0.00169	0.002	CcSEcCtD
Methacholine—Nausea—Thiotepa—breast cancer	0.00168	0.002	CcSEcCtD
Methacholine—Shock—Docetaxel—breast cancer	0.00166	0.00198	CcSEcCtD
Methacholine—Pruritus—Fluorouracil—breast cancer	0.00166	0.00197	CcSEcCtD
Methacholine—Bradycardia—Epirubicin—breast cancer	0.00164	0.00194	CcSEcCtD
Methacholine—Dizziness—Irinotecan—breast cancer	0.00162	0.00192	CcSEcCtD
Methacholine—Shock—Capecitabine—breast cancer	0.00161	0.00191	CcSEcCtD
Methacholine—Hypotension—Docetaxel—breast cancer	0.00158	0.00188	CcSEcCtD
Methacholine—Vomiting—Mitoxantrone—breast cancer	0.00156	0.00185	CcSEcCtD
Methacholine—Vomiting—Irinotecan—breast cancer	0.00156	0.00185	CcSEcCtD
Methacholine—Dizziness—Fluorouracil—breast cancer	0.00155	0.00184	CcSEcCtD
Methacholine—Headache—Mitoxantrone—breast cancer	0.00153	0.00182	CcSEcCtD
Methacholine—Headache—Irinotecan—breast cancer	0.00153	0.00182	CcSEcCtD
Methacholine—Hypotension—Capecitabine—breast cancer	0.00153	0.00182	CcSEcCtD
Methacholine—Vomiting—Gemcitabine—breast cancer	0.00152	0.0018	CcSEcCtD
Methacholine—Bradycardia—Doxorubicin—breast cancer	0.00151	0.0018	CcSEcCtD
Methacholine—Headache—Gemcitabine—breast cancer	0.00149	0.00177	CcSEcCtD
Methacholine—Vomiting—Fluorouracil—breast cancer	0.00149	0.00177	CcSEcCtD
Methacholine—Headache—Fluorouracil—breast cancer	0.00147	0.00174	CcSEcCtD
Methacholine—Nausea—Irinotecan—breast cancer	0.00145	0.00173	CcSEcCtD
Methacholine—Nausea—Mitoxantrone—breast cancer	0.00145	0.00173	CcSEcCtD
Methacholine—Nausea—Gemcitabine—breast cancer	0.00142	0.00168	CcSEcCtD
Methacholine—Pruritus—Paclitaxel—breast cancer	0.00141	0.00168	CcSEcCtD
Methacholine—Nausea—Fluorouracil—breast cancer	0.00139	0.00165	CcSEcCtD
Methacholine—Dizziness—Paclitaxel—breast cancer	0.00132	0.00157	CcSEcCtD
Methacholine—Cough—Methotrexate—breast cancer	0.0013	0.00155	CcSEcCtD
Methacholine—Chest pain—Methotrexate—breast cancer	0.00127	0.00151	CcSEcCtD
Methacholine—Vomiting—Paclitaxel—breast cancer	0.00127	0.00151	CcSEcCtD
Methacholine—Syncope—Epirubicin—breast cancer	0.00125	0.00149	CcSEcCtD
Methacholine—Headache—Paclitaxel—breast cancer	0.00125	0.00149	CcSEcCtD
Methacholine—Loss of consciousness—Epirubicin—breast cancer	0.00123	0.00146	CcSEcCtD
Methacholine—Cough—Epirubicin—breast cancer	0.00122	0.00145	CcSEcCtD
Methacholine—Pruritus—Docetaxel—breast cancer	0.0012	0.00142	CcSEcCtD
Methacholine—Chest pain—Epirubicin—breast cancer	0.00119	0.00141	CcSEcCtD
Methacholine—Nausea—Paclitaxel—breast cancer	0.00119	0.00141	CcSEcCtD
Methacholine—Syncope—Doxorubicin—breast cancer	0.00116	0.00138	CcSEcCtD
Methacholine—Pruritus—Capecitabine—breast cancer	0.00116	0.00138	CcSEcCtD
Methacholine—Hypotension—Methotrexate—breast cancer	0.00114	0.00135	CcSEcCtD
Methacholine—Loss of consciousness—Doxorubicin—breast cancer	0.00114	0.00135	CcSEcCtD
Methacholine—Cough—Doxorubicin—breast cancer	0.00113	0.00134	CcSEcCtD
Methacholine—Shock—Epirubicin—breast cancer	0.00112	0.00133	CcSEcCtD
Methacholine—Dizziness—Docetaxel—breast cancer	0.00112	0.00133	CcSEcCtD
Methacholine—Chest pain—Doxorubicin—breast cancer	0.0011	0.00131	CcSEcCtD
Methacholine—Dizziness—Capecitabine—breast cancer	0.00108	0.00129	CcSEcCtD
Methacholine—Vomiting—Docetaxel—breast cancer	0.00108	0.00128	CcSEcCtD
Methacholine—Hypotension—Epirubicin—breast cancer	0.00107	0.00127	CcSEcCtD
Methacholine—Headache—Docetaxel—breast cancer	0.00106	0.00126	CcSEcCtD
Methacholine—Vomiting—Capecitabine—breast cancer	0.00104	0.00124	CcSEcCtD
Methacholine—Shock—Doxorubicin—breast cancer	0.00104	0.00123	CcSEcCtD
Methacholine—Headache—Capecitabine—breast cancer	0.00103	0.00122	CcSEcCtD
Methacholine—Nausea—Docetaxel—breast cancer	0.001	0.00119	CcSEcCtD
Methacholine—Hypotension—Doxorubicin—breast cancer	0.000987	0.00117	CcSEcCtD
Methacholine—Nausea—Capecitabine—breast cancer	0.000973	0.00116	CcSEcCtD
Methacholine—Pruritus—Methotrexate—breast cancer	0.000863	0.00102	CcSEcCtD
Methacholine—Pruritus—Epirubicin—breast cancer	0.000807	0.000959	CcSEcCtD
Methacholine—Dizziness—Methotrexate—breast cancer	0.000806	0.000958	CcSEcCtD
Methacholine—Vomiting—Methotrexate—breast cancer	0.000775	0.000921	CcSEcCtD
Methacholine—Headache—Methotrexate—breast cancer	0.000764	0.000907	CcSEcCtD
Methacholine—Dizziness—Epirubicin—breast cancer	0.000755	0.000896	CcSEcCtD
Methacholine—Pruritus—Doxorubicin—breast cancer	0.000747	0.000887	CcSEcCtD
Methacholine—Vomiting—Epirubicin—breast cancer	0.000726	0.000862	CcSEcCtD
Methacholine—Nausea—Methotrexate—breast cancer	0.000724	0.00086	CcSEcCtD
Methacholine—Headache—Epirubicin—breast cancer	0.000715	0.000849	CcSEcCtD
Methacholine—Dizziness—Doxorubicin—breast cancer	0.000698	0.000829	CcSEcCtD
Methacholine—Nausea—Epirubicin—breast cancer	0.000678	0.000805	CcSEcCtD
Methacholine—Vomiting—Doxorubicin—breast cancer	0.000671	0.000797	CcSEcCtD
Methacholine—Headache—Doxorubicin—breast cancer	0.000661	0.000786	CcSEcCtD
Methacholine—Nausea—Doxorubicin—breast cancer	0.000627	0.000745	CcSEcCtD
Methacholine—CHRM3—Metabolism—NCOA1—breast cancer	5.81e-05	0.000501	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP19A1—breast cancer	5.72e-05	0.000494	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—STK11—breast cancer	5.72e-05	0.000494	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FLT1—breast cancer	5.68e-05	0.000491	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FGF3—breast cancer	5.66e-05	0.000489	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SQSTM1—breast cancer	5.66e-05	0.000489	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PIK3CG—breast cancer	5.63e-05	0.000486	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FLT1—breast cancer	5.63e-05	0.000486	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FGF3—breast cancer	5.61e-05	0.000484	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SQSTM1—breast cancer	5.61e-05	0.000484	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—JAG1—breast cancer	5.59e-05	0.000482	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PIK3CG—breast cancer	5.58e-05	0.000482	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NOTCH3—breast cancer	5.56e-05	0.00048	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PARP1—breast cancer	5.56e-05	0.00048	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—JAG1—breast cancer	5.53e-05	0.000478	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PARP1—breast cancer	5.51e-05	0.000476	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NOTCH3—breast cancer	5.51e-05	0.000476	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CALCA—breast cancer	5.5e-05	0.000475	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CALCA—breast cancer	5.44e-05	0.00047	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—RPS6—breast cancer	5.43e-05	0.000469	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FGF4—breast cancer	5.39e-05	0.000465	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—RPS6—breast cancer	5.38e-05	0.000464	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CXCR4—breast cancer	5.37e-05	0.000464	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CXCL12—breast cancer	5.37e-05	0.000464	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FGF4—breast cancer	5.34e-05	0.000461	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—COMT—breast cancer	5.32e-05	0.000459	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CXCR4—breast cancer	5.32e-05	0.000459	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CXCL12—breast cancer	5.32e-05	0.000459	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GSTP1—breast cancer	5.3e-05	0.000457	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PAK1—breast cancer	5.27e-05	0.000455	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—HMOX1—breast cancer	5.22e-05	0.000451	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PAK1—breast cancer	5.22e-05	0.000451	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ITPR1—breast cancer	5.21e-05	0.00045	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TCF7L2—breast cancer	5.18e-05	0.000447	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—AKT2—breast cancer	5.15e-05	0.000445	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TCF7L2—breast cancer	5.13e-05	0.000443	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PIK3CG—breast cancer	5.11e-05	0.000442	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—AKT2—breast cancer	5.1e-05	0.000441	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PIK3CG—breast cancer	5.06e-05	0.000437	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ABCB1—breast cancer	5.01e-05	0.000433	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NOTCH2—breast cancer	4.99e-05	0.000431	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HSP90AA1—breast cancer	4.99e-05	0.000431	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PIK3CD—breast cancer	4.95e-05	0.000427	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HSP90AA1—breast cancer	4.94e-05	0.000427	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NOTCH2—breast cancer	4.94e-05	0.000427	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—TYMS—breast cancer	4.92e-05	0.000425	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PIK3CD—breast cancer	4.9e-05	0.000423	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—NCOR1—breast cancer	4.87e-05	0.00042	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PLA2G4A—breast cancer	4.87e-05	0.00042	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GSTM1—breast cancer	4.87e-05	0.00042	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PRL—breast cancer	4.86e-05	0.000419	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AGTR1—breast cancer	4.86e-05	0.000419	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PRL—breast cancer	4.81e-05	0.000415	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AGTR1—breast cancer	4.81e-05	0.000415	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—STK11—breast cancer	4.79e-05	0.000413	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ADAM10—breast cancer	4.79e-05	0.000413	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ADAM10—breast cancer	4.74e-05	0.000409	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—STK11—breast cancer	4.74e-05	0.000409	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PLG—breast cancer	4.73e-05	0.000409	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PLG—breast cancer	4.69e-05	0.000405	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—AKT2—breast cancer	4.68e-05	0.000404	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GPX1—breast cancer	4.66e-05	0.000402	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FGF10—breast cancer	4.65e-05	0.000402	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—AKT2—breast cancer	4.63e-05	0.0004	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP1A1—breast cancer	4.61e-05	0.000398	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FGF10—breast cancer	4.61e-05	0.000398	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ERCC2—breast cancer	4.57e-05	0.000395	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PIK3CD—breast cancer	4.5e-05	0.000388	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PDGFA—breast cancer	4.49e-05	0.000388	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PIK3CD—breast cancer	4.45e-05	0.000384	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PDGFA—breast cancer	4.45e-05	0.000384	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TGFBR2—breast cancer	4.43e-05	0.000382	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TGFBR2—breast cancer	4.38e-05	0.000379	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ITPR1—breast cancer	4.36e-05	0.000376	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ERBB4—breast cancer	4.33e-05	0.000374	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MMP3—breast cancer	4.33e-05	0.000374	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—STAT5A—breast cancer	4.33e-05	0.000374	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PIK3CB—breast cancer	4.32e-05	0.000373	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ITPR1—breast cancer	4.31e-05	0.000373	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—MTHFR—breast cancer	4.3e-05	0.000371	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ERBB4—breast cancer	4.29e-05	0.00037	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MMP3—breast cancer	4.29e-05	0.00037	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—STAT5A—breast cancer	4.29e-05	0.00037	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PIK3CB—breast cancer	4.27e-05	0.000369	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SMAD4—breast cancer	4.19e-05	0.000362	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IGF1R—breast cancer	4.17e-05	0.00036	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SMAD4—breast cancer	4.15e-05	0.000358	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—CXCL8—breast cancer	4.15e-05	0.000358	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IGF1R—breast cancer	4.13e-05	0.000356	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—CXCL8—breast cancer	4.11e-05	0.000355	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HES1—breast cancer	4.09e-05	0.000353	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PLA2G4A—breast cancer	4.07e-05	0.000351	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NCOR1—breast cancer	4.07e-05	0.000351	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HES1—breast cancer	4.05e-05	0.00035	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PLA2G4A—breast cancer	4.03e-05	0.000348	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NCOR1—breast cancer	4.03e-05	0.000348	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CSF2—breast cancer	4.02e-05	0.000347	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FGF1—breast cancer	4.02e-05	0.000347	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—RAF1—breast cancer	4.01e-05	0.000347	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NRG1—breast cancer	3.99e-05	0.000345	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CSF2—breast cancer	3.98e-05	0.000344	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FGF1—breast cancer	3.98e-05	0.000344	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—RAF1—breast cancer	3.97e-05	0.000343	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CAV1—breast cancer	3.97e-05	0.000342	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—H2AFX—breast cancer	3.96e-05	0.000342	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—IL2—breast cancer	3.96e-05	0.000342	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NRG1—breast cancer	3.95e-05	0.000341	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—E2F1—breast cancer	3.94e-05	0.00034	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—H2AFX—breast cancer	3.93e-05	0.000339	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—IL2—breast cancer	3.92e-05	0.000339	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PIK3CB—breast cancer	3.92e-05	0.000338	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—E2F1—breast cancer	3.9e-05	0.000337	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PIK3CB—breast cancer	3.88e-05	0.000335	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SPP1—breast cancer	3.78e-05	0.000327	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CXCL8—breast cancer	3.77e-05	0.000325	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SPP1—breast cancer	3.75e-05	0.000323	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ERBB3—breast cancer	3.74e-05	0.000323	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FGFR2—breast cancer	3.74e-05	0.000323	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CXCL8—breast cancer	3.73e-05	0.000322	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ERBB3—breast cancer	3.7e-05	0.00032	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FGFR2—breast cancer	3.7e-05	0.000319	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PIK3CG—breast cancer	3.61e-05	0.000312	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—IL2—breast cancer	3.6e-05	0.000311	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TERT—breast cancer	3.59e-05	0.00031	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—IL2—breast cancer	3.56e-05	0.000308	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TERT—breast cancer	3.55e-05	0.000307	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FGFR1—breast cancer	3.48e-05	0.000301	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FGFR1—breast cancer	3.45e-05	0.000298	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HIF1A—breast cancer	3.43e-05	0.000296	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HIF1A—breast cancer	3.4e-05	0.000293	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—LEP—breast cancer	3.35e-05	0.000289	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CAV1—breast cancer	3.32e-05	0.000286	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—LEP—breast cancer	3.32e-05	0.000286	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CAV1—breast cancer	3.28e-05	0.000284	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—KDR—breast cancer	3.28e-05	0.000283	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—KDR—breast cancer	3.25e-05	0.00028	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ESR1—breast cancer	3.2e-05	0.000276	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PIK3CD—breast cancer	3.18e-05	0.000274	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ESR1—breast cancer	3.16e-05	0.000273	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FN1—breast cancer	3.16e-05	0.000273	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ALB—breast cancer	3.14e-05	0.000271	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FN1—breast cancer	3.13e-05	0.00027	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NFKBIA—breast cancer	3.12e-05	0.000269	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NOTCH1—breast cancer	3.09e-05	0.000267	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NFKBIA—breast cancer	3.09e-05	0.000267	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NOTCH1—breast cancer	3.06e-05	0.000264	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—KIT—breast cancer	3.02e-05	0.000261	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—APC—breast cancer	3.02e-05	0.000261	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PIK3CG—breast cancer	3.02e-05	0.000261	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—NOS3—breast cancer	3e-05	0.000259	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PIK3CG—breast cancer	2.99e-05	0.000258	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—KIT—breast cancer	2.99e-05	0.000258	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—APC—breast cancer	2.99e-05	0.000258	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—EGF—breast cancer	2.99e-05	0.000258	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—EGF—breast cancer	2.96e-05	0.000255	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—MAPK3—breast cancer	2.89e-05	0.00025	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—MAPK3—breast cancer	2.87e-05	0.000247	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—BRAF—breast cancer	2.84e-05	0.000245	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—BRAF—breast cancer	2.81e-05	0.000243	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PIK3CB—breast cancer	2.77e-05	0.000239	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IGF1—breast cancer	2.77e-05	0.000239	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AKT2—breast cancer	2.76e-05	0.000239	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—EGFR—breast cancer	2.75e-05	0.000238	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PTGS2—breast cancer	2.74e-05	0.000237	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IGF1—breast cancer	2.74e-05	0.000237	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AKT2—breast cancer	2.74e-05	0.000236	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—EGFR—breast cancer	2.73e-05	0.000235	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PIK3CD—breast cancer	2.66e-05	0.000229	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PIK3CA—breast cancer	2.63e-05	0.000227	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PIK3CD—breast cancer	2.63e-05	0.000227	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SERPINE1—breast cancer	2.63e-05	0.000227	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	2.61e-05	0.000225	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SERPINE1—breast cancer	2.6e-05	0.000225	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—KRAS—breast cancer	2.6e-05	0.000225	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—KRAS—breast cancer	2.57e-05	0.000222	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NOS3—breast cancer	2.51e-05	0.000217	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NOS3—breast cancer	2.48e-05	0.000214	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PTEN—breast cancer	2.39e-05	0.000207	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PIK3CA—breast cancer	2.39e-05	0.000206	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MDM2—breast cancer	2.38e-05	0.000205	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—RAF1—breast cancer	2.37e-05	0.000205	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	2.37e-05	0.000204	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—RELA—breast cancer	2.36e-05	0.000204	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MDM2—breast cancer	2.36e-05	0.000203	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—RAF1—breast cancer	2.35e-05	0.000203	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ERBB2—breast cancer	2.35e-05	0.000203	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—RELA—breast cancer	2.34e-05	0.000202	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ERBB2—breast cancer	2.32e-05	0.000201	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MTOR—breast cancer	2.31e-05	0.0002	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PIK3CB—breast cancer	2.31e-05	0.0002	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MTOR—breast cancer	2.29e-05	0.000198	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PIK3CB—breast cancer	2.29e-05	0.000198	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CXCL8—breast cancer	2.22e-05	0.000192	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—HRAS—breast cancer	2.21e-05	0.000191	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CXCL8—breast cancer	2.2e-05	0.00019	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—HRAS—breast cancer	2.19e-05	0.000189	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CDKN1B—breast cancer	2.17e-05	0.000188	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CDKN1B—breast cancer	2.15e-05	0.000186	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—AKT1—breast cancer	2.15e-05	0.000186	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CASP3—breast cancer	2.13e-05	0.000184	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—AKT1—breast cancer	2.13e-05	0.000184	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IL2—breast cancer	2.13e-05	0.000184	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—IL6—breast cancer	2.12e-05	0.000183	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CASP3—breast cancer	2.11e-05	0.000182	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IL2—breast cancer	2.11e-05	0.000182	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—IL6—breast cancer	2.09e-05	0.000181	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCND1—breast cancer	2.07e-05	0.000179	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—JUN—breast cancer	2.07e-05	0.000179	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCND1—breast cancer	2.05e-05	0.000177	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CTNNB1—breast cancer	2.05e-05	0.000177	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—JUN—breast cancer	2.05e-05	0.000177	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CTNNB1—breast cancer	2.03e-05	0.000175	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MMP9—breast cancer	2.01e-05	0.000174	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CDKN1A—breast cancer	2e-05	0.000173	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PTEN—breast cancer	2e-05	0.000173	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MMP9—breast cancer	1.99e-05	0.000172	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CDKN1A—breast cancer	1.99e-05	0.000171	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PTEN—breast cancer	1.98e-05	0.000171	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MAPK8—breast cancer	1.96e-05	0.000169	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—AKT1—breast cancer	1.95e-05	0.000168	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MAPK8—breast cancer	1.94e-05	0.000167	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—AKT1—breast cancer	1.93e-05	0.000167	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SRC—breast cancer	1.86e-05	0.00016	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SRC—breast cancer	1.84e-05	0.000159	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—VEGFA—breast cancer	1.81e-05	0.000156	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—VEGFA—breast cancer	1.79e-05	0.000154	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—STAT3—breast cancer	1.79e-05	0.000154	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—STAT3—breast cancer	1.77e-05	0.000153	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MAPK3—breast cancer	1.71e-05	0.000148	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MAPK3—breast cancer	1.69e-05	0.000146	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PIK3CA—breast cancer	1.69e-05	0.000146	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MYC—breast cancer	1.66e-05	0.000144	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TGFB1—breast cancer	1.66e-05	0.000143	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MYC—breast cancer	1.65e-05	0.000142	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TGFB1—breast cancer	1.64e-05	0.000142	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—EGFR—breast cancer	1.63e-05	0.00014	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—EGFR—breast cancer	1.61e-05	0.000139	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—KRAS—breast cancer	1.54e-05	0.000133	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—KRAS—breast cancer	1.52e-05	0.000131	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PIK3CA—breast cancer	1.41e-05	0.000122	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PIK3CA—breast cancer	1.4e-05	0.000121	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—AKT1—breast cancer	1.38e-05	0.000119	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TP53—breast cancer	1.37e-05	0.000118	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TP53—breast cancer	1.35e-05	0.000117	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HRAS—breast cancer	1.31e-05	0.000113	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HRAS—breast cancer	1.29e-05	0.000112	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IL6—breast cancer	1.25e-05	0.000108	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IL6—breast cancer	1.24e-05	0.000107	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AKT1—breast cancer	1.15e-05	9.95e-05	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AKT1—breast cancer	1.14e-05	9.86e-05	CbGpPWpGaD
